These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 87927)
61. Long-term treatment of onchocerciasis patients from the Liberian rain-forest with low doses of diethylcarbamazine citrate after complete nodulectomy. Albiez EJ Tropenmed Parasitol; 1983 Dec; 34(4):267-70. PubMed ID: 6420965 [TBL] [Abstract][Full Text] [Related]
65. Studies on Bancroftian filariasis in Liberia, West Africa. IV. Notes on side effects observed during a diethylcarbamazine treatment campaign in a rural area endemic for Wuchereria bancrofti and Onchocerca volvulus. Chlebowsky HO; Zielke E Tropenmed Parasitol; 1980 Sep; 31(3):339-44. PubMed ID: 7003853 [TBL] [Abstract][Full Text] [Related]
66. Onchocerciasis. Duke BO Br Med J; 1968 Nov; 4(5626):301-4. PubMed ID: 5687973 [No Abstract] [Full Text] [Related]
68. The chemotherapy of onchocerciasis iii. A comparative study of diethylcarbamazide (DEC) and metrifonate. Awadzi K; Gilles HM Ann Trop Med Parasitol; 1980 Apr; 74(2):199-210. PubMed ID: 7002074 [TBL] [Abstract][Full Text] [Related]
69. Visual dysfunction and methotrexate. Johansson B Acta Ophthalmol Scand; 2004 Oct; 82(5):625. PubMed ID: 15453868 [No Abstract] [Full Text] [Related]
70. Diagnostic and therapeutic challenges. Tranos PG; Moore A; Pavesio C; Acharya NR; Johnson MW Retina; 2012 Jan; 32(1):191-6. PubMed ID: 21886020 [No Abstract] [Full Text] [Related]
71. [Treatment of onchocerciasis with diethylcarbamazine and moranil in nonimmune persons]. Firsova RA; Ozeretskovskaia NN; Kulinich GV; Supriaga VG; Mikhaĭlova VA Med Parazitol (Mosk); 1982; 51(5):33-5. PubMed ID: 7185365 [No Abstract] [Full Text] [Related]
72. Vigabatrin-associated visual field loss. Fecarotta C; Sergott RC Int Ophthalmol Clin; 2012; 52(3):87-94, xii. PubMed ID: 22668542 [No Abstract] [Full Text] [Related]
73. Vigabatrin and visual field disorders. Prescrire Int; 2002 Dec; 11(62):182. PubMed ID: 12472095 [No Abstract] [Full Text] [Related]
74. [Pharmacokinetics of onchocerciasis preparations. 3. Diethylcarbamazine]. Lur'e AA; Ovusu A; Ozeretskovskaia NN Med Parazitol (Mosk); 1988; (2):41-6. PubMed ID: 3412242 [No Abstract] [Full Text] [Related]
75. Topical diethylcarbamazine in the treatment of ocular onchocerciasis. Lazar M; Lieberman TW; Leopold IH Am J Trop Med Hyg; 1970 Mar; 19(2):232-3. PubMed ID: 5443071 [No Abstract] [Full Text] [Related]
76. Clinical and laboratory changes consequent to diethylcarbamazine in patients with onchocerciasis. Fazen LE; Anderson RI; Fazen LE; Marroquin HF Am J Trop Med Hyg; 1976 Mar; 25(2):250-6. PubMed ID: 1259086 [TBL] [Abstract][Full Text] [Related]
77. Topical diethylcarbamazine in ocular onchocerciasis. Aviel E; David R Isr J Med Sci; 1972; 8(8):1166-8. PubMed ID: 4647766 [No Abstract] [Full Text] [Related]
78. Miotic drugs: a review of ocular, visual, and systemic complications. Rengstorff R; Royston M Am J Optom Physiol Opt; 1976 Feb; 53(2):70-80. PubMed ID: 1084694 [TBL] [Abstract][Full Text] [Related]
79. Quantification of the ocular reactions to microfilaricides in the chemotherapy of onchocerciasis. Hero M; Bird AC; Awadzi K Eye (Lond); 1992; 6 ( Pt 1)():93-6. PubMed ID: 1426410 [TBL] [Abstract][Full Text] [Related]